Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TPT1 pseudogene 10 (TPT1P10) is classified as a pseudogene derived from the TPT1 (tumor protein, translationally-controlled 1) gene, which codes for a protein involved in cell growth, microtubule stabilization, apoptosis, and is implicated in various cancers[1][2][3]. However, TPT1P10 is non-protein-coding and has no known biological, diagnostic, or therapeutic function. It does not act as a therapeutic target, and there is no evidence for involvement in disease, pharmacology, or cellular signaling. Systematic pseudogene loci like TPT1P10 are not considered actionable molecular targets and contain only sequence similarity to parental functional genes, which can occasionally complicate molecular diagnostic assays but are otherwise biologically inert. TPT1P10 is not a receptor, enzyme, transporter, or active biomolecule and is not subject to therapeutic intervention or clinical research focus. If a functional role or a disease association is sought, refer to the canonical TPT1 gene/protein, not to its pseudogene relatives[1][2][3]. The query may contain an incorrect premise if the intent was to identify a therapeutic target, as TPT1P10 itself is not one.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TPT1 pseudogene 10 (TPT1P10).